CN102100674A - Febantel chewable tablets for dogs and cats - Google Patents

Febantel chewable tablets for dogs and cats Download PDF

Info

Publication number
CN102100674A
CN102100674A CN 200910255663 CN200910255663A CN102100674A CN 102100674 A CN102100674 A CN 102100674A CN 200910255663 CN200910255663 CN 200910255663 CN 200910255663 A CN200910255663 A CN 200910255663A CN 102100674 A CN102100674 A CN 102100674A
Authority
CN
China
Prior art keywords
febantel
chewable tablet
essence
percent
lubricant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200910255663
Other languages
Chinese (zh)
Inventor
郝智慧
张瑞丽
邱梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QINGDAO LIUHE MEDICINE CO Ltd
QINGDAO CONTINENT BIOTECH CO Ltd
Original Assignee
QINGDAO LIUHE MEDICINE CO Ltd
QINGDAO CONTINENT BIOTECH CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QINGDAO LIUHE MEDICINE CO Ltd, QINGDAO CONTINENT BIOTECH CO Ltd filed Critical QINGDAO LIUHE MEDICINE CO Ltd
Priority to CN 200910255663 priority Critical patent/CN102100674A/en
Publication of CN102100674A publication Critical patent/CN102100674A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The invention discloses febantel chewable tablets for dogs and cats. The active ingredient of the chewable tablets is febantel serving as a broad-spectrum nematodes dispelling medicament. The chewable tablets overcome the defect of poor palatability of the traditional tablets, enable the dogs and the cats to fully chew medicaments, ensure that the medicaments are fully absorbed, and exert good medicinal effect. The tablets comprise the following components in percentage by mass: 20 to 40 percent of febantel, 50 to 70 percent of filling agent, 0.5 to 3 percent of adhesive, and 5 to 15 percent of flavoring agent. The preparation process is simple, and the prepared product has good mouthfeel and stable quality and is suitable for industrialized production.

Description

A kind of dog, cat are used the febantel chewable tablet
Technical field
The present invention relates to a kind of febantel chewable tablet that is used to drive away nematicide in dog, the cat body and preparation method thereof.
Background technology
Nematicide is dog, cat common parasitic disease.Often cause the dysplasia of dog and cat, particularly young animal, poor growth, the toxin that a large amount of nematicides discharge even can cause pup cat quadriplegia can cause death when serious.Febantel belongs to benzimidazole precursor anthelmintic, is used for the antinematodal agent of various animals at U.S.'s approved.The physiological characteristics that absorbs at dog, cat in order to increase the absorption to oral drugs of dog, cat, has been developed the chewable tablet of suitable dog, cat taste, can make dog, cat fully chew medicine, guarantees that medicine is fully absorbed, and brings into play good drug effect.
Summary of the invention
The present invention provides first and has related to a kind of febantel chewable tablet that is used to drive away nematicide in dog, the cat body.
An object of the present invention is to provide a kind of febantel chewable tablet, active component is a febantel, and it has good palatability, advantage that curative effect is high.
Another object of the present invention provides a kind of preparation method of described febantel chewable tablet.
Tablet of the present invention is formed and is comprised: represent to be respectively febantel 20%-40% with mass percent, filler 50%-70%, binding agent 0.5%-3%, correctives 5%-15%.
The lubricant that also contains 0.1%-2% in the described chewable tablet.
Wherein said filler is one or more in sucrose, sucrose mixture, starch, microcrystalline Cellulose, glucose, lactose, amylum pregelatinisatum, Icing Sugar, inorganic salt, the mannitol.
In the polyvidone aqueous solution that adhesive is water, percent by volume are the ethanol water of 5%-30%, starch slurry that mass percent is 1%-15%, mass percentage concentration is 1%-15% a cellulose derivative aqueous solution, mass percentage concentration is 1%-15%, the aqueous gelatin solution that mass percentage concentration is 1%-15%, the Polyethylene Glycol aqueous solution that mass percentage concentration is 1%-15% any.
Correctives is one or more in beef flavor, chicken essence, shrimp flavor essence, Carnis caprae seu ovis essence, duck meat essence, Carnis Anseris domestica essence, crab meat essence, the smart cream.
Lubricant is one or more in magnesium stearate, micropowder silica gel, the Pulvis Talci.
The invention also discloses a kind of preparation method of febantel chewable tablet: febantel and the filler back of sieving is respectively mixed, add adhesive system soft material, granulate, drying, granulate, adding correctives, lubricant are with dried granule mixing, tabletting, promptly.
Most preferred preparation method is that febantel and filler are crossed mix homogeneously behind 100 mesh sieves respectively, with an amount of ethanol system soft material, and the granulation of 20 mesh sieves, drying, 20 mesh sieve granulate, adding correctives, lubricant, mixing, tabletting, promptly.
Febantel chewable tablet of the present invention, the taste design at dog, cat are liked has good mouthfeel, and dog, cat compliance are increased, and improves the oral administration biaavailability of medicine.
The specific embodiment
The following embodiment that provides just in order to help to understand the present invention, rather than constitutes protection domain of the present invention is played restrictive effect, under design prerequisite of the present invention the present invention is simply changed, and all belongs to the scope of protection of present invention.
Embodiment 1:
Prescription is formed:
Febantel 20mg
Microcrystalline Cellulose 23mg
Starch 40mg
Magnesium stearate 2mg
Beef flavor 15mg
Every total amount 100mg
Preparation method: febantel and microcrystalline Cellulose, starch are crossed mix homogeneously behind 100 mesh sieves respectively, with an amount of ethanol system soft material, and the granulation of 20 mesh sieves, drying, 20 mesh sieve granulate, adding beef flavor, magnesium stearate, mixing, tabletting, promptly.
Embodiment 2:
Prescription is formed:
Prescription is formed:
Febantel 20mg
Microcrystalline Cellulose 23mg
Starch 15mg
Sucrose 25mg
Magnesium stearate 2mg
Beef flavor 15mg
Every total amount 100mg
Preparation method: febantel and microcrystalline Cellulose, starch, sucrose are crossed mix homogeneously behind 100 mesh sieves respectively, with an amount of ethanol system soft material, and the granulation of 20 mesh sieves, drying, 20 mesh sieve granulate, adding beef flavor, magnesium stearate, mixing, tabletting, promptly.

Claims (9)

1. a dog, cat are used the febantel chewable tablet, it is characterized in that component and mass percent are respectively febantel 20%-40%, filler 50%-70%, binding agent 0.5%-3%, correctives 5%-15%.
2. according to the described febantel chewable tablet of claim 1, it is characterized in that containing the lubricant of 0.1%-2%.
3. according to the described febantel chewable tablet of claim 1, it is characterized in that containing febantel 20mg-40mg.
4. according to the described febantel chewable tablet of claim 1, it is characterized in that described filler is one or more in sucrose, sucrose mixture, starch, microcrystalline Cellulose, glucose, lactose, amylum pregelatinisatum, Icing Sugar, inorganic salt, the mannitol.
5. according to the described febantel chewable tablet of claim 1, it is characterized in that in described adhesive is water, percent by volume are the ethanol water of 5%-30%, starch slurry that mass percent is 1%-15%, mass percentage concentration is 1%-15% a cellulose derivative aqueous solution, mass percentage concentration is 1%-15% polyvidone aqueous solution, aqueous gelatin solution that mass percentage concentration is 1%-15%, the Polyethylene Glycol aqueous solution that mass percentage concentration is 1%-15% any.
6. according to the described febantel chewable tablet of claim 1, it is characterized in that described correctives is one or more in beef flavor, chicken essence, shrimp flavor essence, Carnis caprae seu ovis essence, duck meat essence, Carnis Anseris domestica essence, crab meat essence, the smart cream.
7. according to the described febantel chewable tablet of claim 2, it is characterized in that described lubricant is one or more in magnesium stearate, micropowder silica gel, the Pulvis Talci.
8. according to the preparation method of the described febantel chewable tablet of claim 1, it is characterized in that febantel and the filler back of sieving is respectively mixed, add adhesive system soft material, granulate, drying, granulate, adding correctives, lubricant, mixing, tabletting, promptly.
9. according to the preparation method of the described febantel chewable tablet of claim 1, it is characterized in that febantel and filler are crossed mix homogeneously behind 100 mesh sieves respectively, add adhesive system soft material, the granulation of 20 mesh sieves, drying, 20 mesh sieve granulate add correctives, lubricant, mixing, tabletting, promptly.
CN 200910255663 2009-12-16 2009-12-16 Febantel chewable tablets for dogs and cats Pending CN102100674A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200910255663 CN102100674A (en) 2009-12-16 2009-12-16 Febantel chewable tablets for dogs and cats

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200910255663 CN102100674A (en) 2009-12-16 2009-12-16 Febantel chewable tablets for dogs and cats

Publications (1)

Publication Number Publication Date
CN102100674A true CN102100674A (en) 2011-06-22

Family

ID=44153874

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200910255663 Pending CN102100674A (en) 2009-12-16 2009-12-16 Febantel chewable tablets for dogs and cats

Country Status (1)

Country Link
CN (1) CN102100674A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106580896A (en) * 2016-12-07 2017-04-26 成都乾坤动物药业股份有限公司 Febantel dispersible tablet and preparation method thereof
CN107158104A (en) * 2017-05-02 2017-09-15 河北省农林科学院经济作物研究所 It is a kind of to strengthen immune chewable tablets
WO2018119837A1 (en) * 2016-12-29 2018-07-05 刘�文 Cat feed containing nanocrystalline cellulose
CN111494327A (en) * 2020-06-23 2020-08-07 瑞阳制药有限公司 Preparation method of mebendazole chewable tablet

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106580896A (en) * 2016-12-07 2017-04-26 成都乾坤动物药业股份有限公司 Febantel dispersible tablet and preparation method thereof
WO2018119837A1 (en) * 2016-12-29 2018-07-05 刘�文 Cat feed containing nanocrystalline cellulose
CN107158104A (en) * 2017-05-02 2017-09-15 河北省农林科学院经济作物研究所 It is a kind of to strengthen immune chewable tablets
CN107158104B (en) * 2017-05-02 2021-02-05 河北省农林科学院经济作物研究所 Chewable tablet for enhancing immunity
CN111494327A (en) * 2020-06-23 2020-08-07 瑞阳制药有限公司 Preparation method of mebendazole chewable tablet
CN111494327B (en) * 2020-06-23 2023-09-05 瑞阳制药股份有限公司 Preparation method of mebendazole chewable tablet

Similar Documents

Publication Publication Date Title
AU2006298895B2 (en) Pharmaceutical preparation containing meloxicam
US8840924B2 (en) Compositions and methods of making rapidly dissolving ionically masked formulations
EP2331076B1 (en) Chewable sustained release formulations
JP5579132B2 (en) Water soluble meloxicam granules
JP6290081B2 (en) Composition for oral administration to animals, production method thereof and use thereof
CN102526058A (en) Anti-inflammatory analgesic medicinal composition containing lornoxicam and esomeprazole
BR112020003235A2 (en) oral compositions and methods of preparing them
CN102100674A (en) Febantel chewable tablets for dogs and cats
CN102512386A (en) Amoxicillin or amoxicillin and clavulanate potassium instant chewable tablets for pet and preparation method for same
CN103751201A (en) Anti-parasitic orally disintegrating tablet for dogs and cats and preparation method thereof
EP2934490B1 (en) Tablets with improved acceptance and good storage stability
CN102526007B (en) Florfenicol taste masking preparation and preparation method for same
CN1742956A (en) Lonicera and Forsythia effervescent tablet for relieving internal heat or fever of humanbody
CN103705479B (en) A kind of pet Meloxicam sustained release tablets and preparation method thereof
CN103877092A (en) Compound niclosamide chewing tablet used for dogs and cats
CN105232486A (en) Flunixin meglumine taste masking orally-disintegrating preparation and preparing method thereof
CN104127389A (en) Praziquantel chewing tablet for pets and preparation method thereof
CN108324700A (en) A kind of enteric slow release oxytetracycline calcium pre-mixing agent and preparation method thereof
CN114796140A (en) Good-palatability milbemycin oxime praziquantel soft chewable tablets for animals and preparation method thereof
CN103083320A (en) Compound febantel chewable tablet for dogs and cats
CN102872013A (en) Anti-parasitic disease compound Triclabendazole granule for flocks and herds and preparation method for anti-parasitic disease compound Triclabendazole granule
CN114727622A (en) Palatable granular veterinary compositions
CN112353774B (en) Nascitide flavor chewable tablet, preparation method thereof and application thereof to clostridium welchii disease of dog
CN101693019A (en) Doxycycline hydrochloride oral disintegrating tablet for domestic fowls and preparation method thereof
CN106727374A (en) A kind of aureomycin hydrochloride chewable tablets for animals and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110622